515 related articles for article (PubMed ID: 15568888)
1. Pharmacokinetics of antiretrovirals in pregnant women.
Mirochnick M; Capparelli E
Clin Pharmacokinet; 2004; 43(15):1071-87. PubMed ID: 15568888
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.
Barry M; Mulcahy F; Merry C; Gibbons S; Back D
Clin Pharmacokinet; 1999 Apr; 36(4):289-304. PubMed ID: 10320951
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.
Else LJ; Taylor S; Back DJ; Khoo SH
Antivir Ther; 2011; 16(8):1149-67. PubMed ID: 22155899
[TBL] [Abstract][Full Text] [Related]
4. Delavirdine: a review of its use in HIV infection.
Scott LJ; Perry CM
Drugs; 2000 Dec; 60(6):1411-44. PubMed ID: 11152019
[TBL] [Abstract][Full Text] [Related]
5. Pharmacology of antiretroviral drugs.
Hoetelmans RM
Antivir Ther; 1999; 4 Suppl 3():29-41. PubMed ID: 16021869
[TBL] [Abstract][Full Text] [Related]
6. Amprenavir or fosamprenavir plus ritonavir in HIV infection: pharmacology, efficacy and tolerability profile.
Arvieux C; Tribut O
Drugs; 2005; 65(5):633-59. PubMed ID: 15748098
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
8. Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
Mirochnick M; Best BM; Stek AM; Capparelli EV; Hu C; Burchett SK; Rossi SS; Hawkins E; Basar M; Smith E; Read JS;
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):412-9. PubMed ID: 21283017
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.
Roustit M; Jlaiel M; Leclercq P; Stanke-Labesque F
Br J Clin Pharmacol; 2008 Aug; 66(2):179-95. PubMed ID: 18537960
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.
Goebel FD; MacGregor TR; Sabo JP; Castles M; Johnson PA; Legg D; McCallister S
HIV Clin Trials; 2010; 11(1):28-38. PubMed ID: 20400409
[TBL] [Abstract][Full Text] [Related]
11. Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.
Waters LJ; Moyle G; Bonora S; D'Avolio A; Else L; Mandalia S; Pozniak A; Nelson M; Gazzard B; Back D; Boffito M
Antivir Ther; 2007; 12(5):825-30. PubMed ID: 17713166
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy.
Kreitchmann R; Best BM; Wang J; Stek A; Caparelli E; Watts DH; Smith E; Shapiro DE; Rossi S; Burchett SK; Hawkins E; Byroads M; Cressey TR; Mirochnick M
J Acquir Immune Defic Syndr; 2013 May; 63(1):59-66. PubMed ID: 23392467
[TBL] [Abstract][Full Text] [Related]
13. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals.
McCormack SA; Best BM
Clin Pharmacokinet; 2014 Nov; 53(11):989-1004. PubMed ID: 25223699
[TBL] [Abstract][Full Text] [Related]
14. The history of antiretrovirals: key discoveries over the past 25 years.
De Clercq E
Rev Med Virol; 2009 Sep; 19(5):287-99. PubMed ID: 19714702
[TBL] [Abstract][Full Text] [Related]
15. Antiretrovirals.
Temesgen Z; Wright AJ
Mayo Clin Proc; 1999 Dec; 74(12):1284-301. PubMed ID: 10593358
[TBL] [Abstract][Full Text] [Related]
16. Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy.
Bukkems VE; Smolders EJ; Jourdain G; Burger DM; Colbers AP; Cressey TR;
J Clin Pharmacol; 2021 Mar; 61(3):388-393. PubMed ID: 32960984
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral Therapy in the Real World : Population-Based Pharmacoeconomic Analysis of Administration of Anti-HIV Regimens to 990 Patients.
Sabbatani S; Manfredi R; Biagetti C; Chiodo F
Clin Drug Investig; 2005; 25(8):527-35. PubMed ID: 17532696
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
Else LJ; Taylor S; Back DJ; Khoo SH
Antivir Ther; 2011; 16(8):1139-47. PubMed ID: 22155898
[TBL] [Abstract][Full Text] [Related]
19. Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq E
Int J Antimicrob Agents; 2009 Apr; 33(4):307-20. PubMed ID: 19108994
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.
Lorenzi P; Spicher VM; Laubereau B; Hirschel B; Kind C; Rudin C; Irion O; Kaiser L
AIDS; 1998 Dec; 12(18):F241-7. PubMed ID: 9875571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
